Siga Technologies (SIGA) Non Operating Income (2010 - 2025)
Siga Technologies (SIGA) posted Non Operating Income of $1.9 million for Q3 2025, up 17.23% on a QoQ basis from $1.6 million in Q2 2025, and up 40.3% year-over-year from $1.3 million in Q3 2024.
Siga Technologies (SIGA) Non Operating Income (2010 - 2025) Analysis & Trends
Siga Technologies' Non Operating Income history runs 16 years deep, the most recent figure standing at $1.9 million for Q3 2025.
- Quarterly Non Operating Income rose 40.3% year-over-year to $1.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $6.7 million (up 14.19% YoY) and the FY2024 annual result came in at $6.1 million, up 45.24% from the prior year.
- Non Operating Income was $1.9 million for Q3 2025 at Siga Technologies, up from $1.6 million in the prior quarter.
- Across five years, Non Operating Income topped out at $1.9 million in Q1 2024 and bottomed at $23322.0 in Q1 2022.
- A 5-year average of $889464.5 and a median of $1.0 million in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2021 — Non Operating Income slumped 93.8% — and 2022, when it jumped 3881.37%.
- Siga Technologies' Non Operating Income stood at $25117.0 in 2021, then soared by 3881.37% to $1.0 million in 2022, then climbed by 23.55% to $1.2 million in 2023, then gained by 22.14% to $1.5 million in 2024, then increased by 23.7% to $1.9 million in 2025.
- Business Quant data shows SIGA's Non Operating Income at $1.9 million in Q3 2025, $1.6 million in Q2 2025, and $1.7 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 883,148.00 |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 890,629.00 |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 258,975.00 |
| Jun 30, 2022 | 72,373.00 |
| Mar 31, 2022 | 23,322.00 |
| Dec 31, 2021 | 25,117.00 |
| Sep 30, 2021 | 26,252.00 |
| Jun 30, 2021 | 24,235.00 |
| Mar 31, 2021 | 25,568.00 |
| Dec 31, 2020 | 62,859.00 |